Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Wealth planning strategies help safeguard and increase your assets. Discover the best methods to secure your financial future.
15,484 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A high-earning retiree with a large pension quietly unlocks Medicare’s IRMAA top tier. The result: higher monthly bil...
A practical look at retiring in the Asheville mountains by 65 on $975,000, factoring in rising costs, insurance, and ...
A thoughtful tribute to a public figure whose approach to tax policy blends discipline with cooperation. This piece p...
Families want a holiday budget that lasts beyond December. A growing-dividend portfolio aims to turn Christmas spendi...
The crowd may be selling Intuitive Surgical too quickly. A Goldman Sachs perspective argues the long-term setup remai...
A top financial executive recently disclosed a share sale at Robinhood. This article breaks down what the move means,...
Global markets jump and contracts tighten as trump’s sudden decision hike lifts the tariff rate to 15% worldwide, ove...
Perplexity returns from a quiet stretch with a cloud-based, OpenClaw-inspired workspace geared for non-experts. The m...
A Seoul woman is accused of using an AI chatbot to help plan two fatal motel visits, sparking questions about AI safe...
A major fund disclosed a sizable NEU share sale. This article unpacks what the move signals, how to interpret it, and...
Federal staffing declines coincide with recent terrorist incidents, prompting concerns that the u.s. faces elevated t...